drugset

drugset / Trial / NCT00004938

Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis

NCT00004938 ↗

Phase 2 Completed 30 enrolled National Institute of Allergy and Infectious Diseases (NIAID) University of Alabama at Birmingham · collab

RandomizedTreatment

Summary

OBJECTIVE: I. Evaluate the efficacy of fluconazole in patients with lymphocutaneous or visceral sporotrichosis.

Timeline

Start: 1996-08
Primary completion: —
Completion: 1996-08

Publications

Background Kauffman CA, Pappas PG, McKinsey DS, Greenfield RA, Perfect JR, Cloud GA, Thomas CJ, Dismukes WE. Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. Clin Infect Dis. 1996 Jan;22(1):46-50. doi: 10.1093/clinids/22.1.46.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fluconazole	Small molecule	—	Oral

Indications